| 1 |
Volk ML, Marrero JA. Early detection of liver cancer: diagnosis and management. Current gastroentero reports, 2008, 10(1): 60-66.
|
| 2 |
高磊，经翔，赵新民, 等. 超声造影和彩色多普勒超声对小肝癌的诊断价值及对比分析. 中国慢性病预防与控制, 2009, 17(3): 261-263.
|
| 3 |
Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology, 2001, 218(3): 763-767.
|
| 4 |
Zhao H, Yao JL, Wang Y, et al. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroentero, 2007, 13(8): 1252.
|
| 5 |
Li L, Wu PH, Mo YX, et al. CT arterial portography and CT hepatic arteriography in detection of micro liver cancer. World J Gastroentero, 1999, 5(3): 225-227.
|
| 6 |
Sahani DV, Holalkere NS, Mueller PR, et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue—initial experience. Radiology, 2007, 243(3): 736-743.
|
| 7 |
王爽，赵心明，林蒙, 等. 肝脏CT灌注成像在肝癌早期诊断中的价值. 放射学实践, 2008, 23(3): 280-284.
|
| 8 |
张月浪，孙兴旺，强永乾. 腹部磁共振扩散加权成像的临床应用. 实用放射学杂志, 2005, 21(3): 313-315.
|
| 9 |
Moteki T, Horikoshi H, Oya N, et al. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images. J Magnetic Resonance Imaging, 2002, 15(5): 564-572.
|
| 10 |
刘志兰，李晓娟，王巍, 等. 磁共振扩散加权成像对肝癌的诊断及鉴别诊断作用. 世界华人消化杂志, 2007, 15(13): 1516-1519.
|
| 11 |
Yoshioka H, Takahashi N, Yamaguchi M, et al. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magnetic Resonance Imaging, 2002, 16(3): 259-266.
|
| 12 |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of surgery, 2006, 243(3): 321.
|
| 13 |
Liu Z, Zhou Y, Zhang P, et al. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech, 2010, 20(3): 130-140.
|
| 14 |
Angonese C, Baldan A, Cillo U, et al. Complications of radiofrequency thermal ablation in hepatocellular carcinoma: what about "explosive" spread? Gut, 2006, 55(3): 435-436.
|
| 15 |
Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging, 2005, 30(4): 409-418.
|
| 16 |
Liang HH, Peng ZW, Zhang YJ, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol, 2008, 15(12): 3484-3493.
|
| 17 |
Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol, 2007, 14(8): 2319-2329.
|
| 18 |
Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology, 1992, 16(2): 353-357.
|
| 19 |
Clark TW. Chemical ablation of liver cancer. Tech Vasc Interv Radiol, 2007, 10(1): 58-63.
|
| 20 |
Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma≤4 cm. Gastroenterology, 2004, 127(6): 1714-1723.
|
| 21 |
Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 2002, 359(9319): 1734-1739.
|
| 22 |
Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002, 35(5): 1164-1171.
|
| 23 |
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology, 2003, 37(2): 429-442.
|
| 24 |
Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Inter Radiol, 2007, 30(1): 6-25.
|
| 25 |
郭珊珊，余玲，周伟生. 经肝动脉化疗栓塞术后血管生成及其对策. 中国介入影像与治疗学, 2009, 6(6): 582-585.
|
| 26 |
Malagari K, Pomoni M, Kelekis A, et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Inter Rad, 2010, 33(3): 541-551.
|
| 27 |
Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Inter Rad, 2010, 33(1): 41-52.
|
| 28 |
Liapi E, Geschwind J-FH. Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Inter Rad, 2011, 34(1): 37-49.
|
| 29 |
Poon RT, Tso WK, Pang RW, et al. A phaseⅠ/Ⅱ trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroentero and Hepatol, 2007, 5(9): 1100-1108.
|
| 30 |
Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 2006, 16(3): 661-669.
|
| 31 |
Yamagiwa K, Shiraki K, Yamakado K, et al. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol, 2007, 23(3): 482-490.
|
| 32 |
Kim JW, Kim JH, Won HJ, et al. Hepatocellular carcinomas 2-3cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol, 2012, 81(3): e189-e193.
|
| 33 |
Kim JH, Won HJ, Shin YM, et al. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol, 2011, 18(6): 1624-1629.
|